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Abstract
Introduction Approximately 10–15% of all fractures of
long bones heal with delay, prolonged immobilization and
repetitive operative interventions. Despite intense investi-
gations, the pathomechanism of impaired healing of skel-
etal tissue remains unclear. An important role in the
pathomechanism of mal-union of close fractures plays
subclinically proceeding infections.
Aim The question arises whether colonization and pro-
liferation of bacteria in the fracture gap could be related to
the mutation of genes for factors regulating local antimi-
crobial response, such as pathogen recognizing receptors
(PRR), cytokines and chemokines.
Methods We carried out studies in patients with delayed
long bone fractures estimating the frequency of mutation of
genes crucial for pathogen recognition (TLR2, TLR4 and
CD14),andelimination(CRP,IL-6,IL-1ra),aswellaswound
healing (TGF-b). The molecular milieu regulating healing
process (IGF-1, COLL1a, TGF-b,B M P - 2 ,a n dP D G F )w a s
validated by Western blot analysis of the gap tissue.
Results Microbiological investigations showed the pres-
ence of viable bacterial strains in 34 out of 108 gaps in
patients with non-healing fractures (31.5%) and in 20 out of
122 patients with uneventful healing (16.4%) (P\0.05).
Theoccurrence ofmutated TLR4 1/W butnot2/W gene was
signiﬁcantly higher (P\0.05) in the non-healing infected
than sterile group. In the non-healing infected group 1/W
mutated gene frequency was also higher than in healing
infected. In the TGF-b codon 10 a signiﬁcantly higher fre-
quency of mutated homozygote T and heterozygote C/T in
thenon-healinginfectedversusnon-healingsterilesubgroup
wasobserved(P\0.05).Similardifferencewasobservedin
the non-healing infected versus healing infected subgroup
(P\0.05). The CRP (G1059C), IL1ra (genotype 2/2), IL-6
(G176C), CD14 (G-159T), TLR2 (G2259A) and TLR4/2
(Thr399Ile) polymorphisms did not play evident role in the
delay of fracture healing.
Conclusions Individuals bearing the mutant TLR 4 gene
1/W (Asp299Gly) and TGF-b gene codon 10 mutant T and
T/C allele may predispose to impaired pathogen recogni-
tion and elimination, leading to prolonged pathogen exis-
tence in the fracture gaps and healing delays.
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Introduction
Approximately 10–15% of all fractures heal in a delayed
fashion with prolonged immobilization and repetitive
operative interventions [1]. Despite intense investigations,
the pathomechanism of impaired healing of skeletal tissue
remains unclear. Clinical and experimental studies brought
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tors, cytokines and chemokines regulating cellular events
proceeding in the fracture gap [2, 3]. They also showed
markedly lowered or lack of expression of molecules cru-
cial for fracture healing [4–6].
A special, until recently not fully recognized, role in the
pathomechanism of non-union plays subclinically pro-
ceeding infection at the site of fractured bone. We reported
previously about the presence of pathogens in closed
fracture gaps without clinically evident inﬂammation.
Using microbiological cultures, bacterial cells were iso-
lated from 35% of closed fractures with delayed healing
and also in 14% of uneventfully healing fractures [7].
The question arose what were the phenotypes of callus
bacterial isolates and whether colonization and prolifera-
tion of bacteria in the fracture gap could be related to
individual predilection depending on mutation of genes for
molecular factors regulating local antimicrobial and
inﬂammatory response, such as pathogen recognizing
receptors (PRR), cytokines and chemokines.
We carried out bacteriological and genetic studies in
patients with delayed and uneventful healing of long bone
closedfractures.Calluswasharvestedfromfracturegapsfor
microbial culture and detection of bacterial 16S RNA. The
frequencyofallele ofgenes crucialforpathogenrecognition
(toll-like receptors TLR2 and TLR4 and CD14) and elimi-
nation(CRP,interleukinsIL-6andIL-1ra),aswellaswound
healing (transforming growthfactor,TGF-b) was estimated.
The molecular protein milieu regulating healing including
factorsasinsulin-likegrowth factor (IGF-1),collagentype 1
(COL1A), TGF-b, bone morphogenetic protein 2 (BMP-2),
and platelet derived growth factor (PDGF) were validated in
callus by western blot analysis.
Patients
Investigationswereperformedinrandomlyselectedgroupof
295 patients, in an order as they were registered in our out-
patients’ clinic. They were undergoing routine post-injury
check-up 6 months after sustaining closed fractures of tibia,
ﬁbulaorfemur.Therewere151patientswithdelayed(group
A) and 144 with uneventful bone healing (group B). The
bonereparativeprocesswasevaluatedclinicallyandwiththe
use of imaging techniques. Lack of bone union was diag-
nosed 6 months after fracture, if there were (1) pathologic
movements in fracture gap with pain and (2) non-union on
standard X-ray pictures in two perpendicular planes. In
uncertain cases the CT and NMR scans were used.
Uneventful healing was recognized in cases without patho-
logicalmovementsinfracturegap,callusvisibleonatleast3
of 4 cortex layers on X-ray pictures taken in perpendicular
position.Excludedwerepatientswith:(1)openfractures,(2)
massive contusion of soft tissues covering the fracture gap,
(3) trophic lesions of soft tissues, (4) chronic inﬂammatory
foci and (5) diseases requiring medication with immuno-
suppressive drugs. The control group for genetic studies
consisted of 125 healthy blood donors from the ethnically
samePolishpopulation.StudieswereapprovedbytheEthics
CommitteeoftheMedicalUniversity,Warsaw,accordingto
the international regulations.
Harvesting of the tissue specimens for microbiological
and protein studies
Tissue specimens were harvested during operative inter-
ventions: in group A correcting delayed bone union, and in
group B during operative treatment of bone non-alignment.
Skin was sterilized three-times using SkinSept (B. Braun,
Meisungen, Germany) and strict antimicrobial regime was
maintained during operation and tissue harvesting. Rou-
tinely performed bacteriological cultures from disposable
scalpel blade, surgeon’s gloves and air in the operating
theater validated the sterility of the operation ﬁeld. Gran-
ulation tissue from the fracture gap and adjacent soft tis-
sues were taken and transported in sterile, disposable
containers (Blue Max, 352070, Becton–Dickinson, USA).
They were cultured on culture media: BHI (Difco, USA),
liquid Hemoline (bioMerieux, Paris, France), blood agar,
Columbia agar enriched with 5% sterile gout serum,
MacConkey’s agar, Chapman’s agar, and Sabouraud agar
(Oxoid,Oxford, UK) for at least 14 days. Isolates were
analyzed biochemically using ApiStaph, ATB G(-),
ApiNG and Api30E (bioMerieux, Paris, France).
Venous blood for genetic investigations
DNA was isolated from leukocytes isolated from venous
blood obtained from the cubital vein.
Isolation of DNA
Genomic DNA was isolated from whole blood using Nu-
cleoSpin Kit, according to the manufacturer’s instructions
(Marcherey-Nagel, Dueren, Germany). Quality of isolated
DNA was checked electrophoretically on 1% agarose gels
with ethidium bromide. Quantiﬁcation of DNA was per-
formed spectrophotometrically on ND-1000 spectropho-
tometer (Nanodrop, Wilmington, USA).
RFLP-polymerase chain reaction analysis of gene
polymorphism
Polymerase chain reaction (PCR) was performed employing
FastStart Taq DNA polymerase (Roche, Mannheim, Ger-
many) in a 25 ll reaction mixture containing 5 llg e n o m i c
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ribonucleoside trisphosphate mix (Sigma-Aldrich, St. Louis,
USA) and 30 pmol each forward and reverse primers (Oligo,
Warsaw,Poland)(Table 1).Ampliﬁcationwascarriedoutina
Thermal Cycler (MJ Research, Watertown, USA).
PCR analysis of bacterial 16S rRNA
16S rRNA genomic DNA was prepared following manu-
facturer’s protocol (High Pure PCR Template Preparation
Kit, Roche, Mannheim, Germany). PCR was performed
employing RedAllegroTaq DNA polymerase (Novazym,
Poznan, Poland) in a 25 ll reaction mixture containing 5 ll
genomic DNA solution, 2.5 ll1 0 9 buffer with MgCl2,
0.5 ll deoxyribonucleoside trisphosphate mix (Sigma-
Aldrich, St. Louis, USA), 0.5 ll anti-inhibitor (DNA-
Gdansk, Poland), 5 ll GC-rich (Roche Mannheim, Ger-
many) and 25 pmol each forward and reverse primers
(Oligo, Warsaw, Poland). Ampliﬁcation was carried out in
a thermal cycler (MJ Research, Watertown, USA).
Western blotting
Callus protein sediment was prepared using Total Protein
Extraction Kit (Millipore, Billerica, USA) according to
manufacturerprotocol.Sequencedproteinsweremovedfrom
polyacrylamide gel to PVDF membrane (Porablot PVDF–
PVDF membrane, Macherey–Nagel, Duren, Germany) using
TRANS-BLOTSD,SEMIDRYTRANSFERCELL(Biorad,
Hercules,USA),thenincubatedwithI-gradeantibody(BMP-
2, Col1A1, PDGF-A, TGF-b1/2/3, and IGF-I, Santa Cruz
Biotechnology, USA). Membrane was incubated with II-
grade antibody conjugated with alkaline phosphatase (goat
anti-rabbit AP, rabbit anti-goat AP, Santa Cruz Biotechnol-
ogy, USA). For protein detection, membrane was incubated
with Alkaline Phosphatase Conjugate Substrate Kit (Biorad,
Hercules, USA).Protein expressionwas validatedcomparing
obtained results with marker (Novex Sharp Protein Standard,
Invitrogen, California, USA).
The results are presented as the ratio of target protein
over GAPDH protein expression.
Statistical methods
The obtained results were analyzed statistically using
standard v
2 and Fisher’s v
2 tests.
Results
Microbiological evaluation
Microbiological investigations showed the presence of
viable bacterial strains in 34 out of 108 gaps (31.5%) in
Table 1 Primers and parameters for PCR sequencing
Gene Primer sequence (from 50 to 30) Parameters of PCR Restriction
enzymes
CRP F: GATCTGTGTGATCTGAGAAACCTCCT
R: GAGGTACCAGAGACAGAGACGTG
9550; 30 cycles (943000,6 2 10,7 2 3000), 72100 MaeIII
CCR2 F: GAAAGTGGATTGAACAAGGA
R: CAGGTTGAGCAGGTAAATGT
9550; 30 cycles (943000,5 8 3000,7 2 3000), 72100 FokI
CD14 F: GTGCCAACAGATGAGGTTCA
R: CGCAGCGGAAATCTTCATC
9550; 30 cycles (943000,5 8 3000,7 2 3000), 72100 HaeIII
TGF-b F: TCGCGGGTGCTGTTGTACA
R: TTCAAGACCACCCACCTTCT
9450; 35 cycles (943000,5 8 3000,7 2 3000), 72100 FseI
TLR2 F: GCCTACTGGGTGGAGAACCT
R: GGCCACTCCAGGTAGGTCTT
95100; 35 cycles (943000,6 0 3000,7 2 3000), 72100 AciI
TLR4 (1) F: GATTAGCATACTTAGACTACTACCTCCATG
R: GATCAACTTCTGAAAAAGCATTCCCAC
9540; 30 cycles (953000,5 5 3000,7 2 3000), 72100 NcoI
TLR4 (2) F: GGTTGCTGTTCTGAAAGTGATTTTGGGAGAA
R: ACCTGAAGACTGGAGAGTGAGTTAAATGCT
9540; 30 cycles (953000,5 5 3000,7 2 3000), 72100 HinfI
IL-6 F: CTGATTGGAAACCTTATTAAG
R: TGACTTCAGCTTTACTCTTGT
9550; 30 cycles (943000,4 8 3000,7 2 3000), 72100 Hsp92II
IL-1ra F: CTCAGCAACACTCCTAT
R: TCCTGGTCTGCAAGGTAA
9550; 30 cycles (943000,6 0 3000,7 2 3000), 72100 –
16S RNA F: AGTTTGATCCTGGCTCAG
R: GGACTACCAGGGTATCTAAT
95150; 35 cycles (604500,7 2 1000,9 5 4500,6 0 4500,
726000), 72100
–
F forward, R reverse
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123patients with non-healing fractures (group A), and in 20 of
122 gaps (16.4%) in patients with uneventful healing
fractures (group B) (P\0.05). Viable pathogens were
isolated in 12 out of 55 biopsies of adjacent soft tissues
(subcutaneous fat, striated muscle, and periosteum) in
patients from group A (21.8%) and in 9 out of 43 patients
from group B (20.9%; NS). In 80% of cases from group A
and 59% from group B isolated pathogens belonged to
staphylococci (P\0.05). The most common strains were
S. epidermidis and S. aureus. Occasionally Micrococcus
spp., Enterococcus spp., and Pseudomonas spp. were iso-
lated in both groups.
Ampliﬁcation of bacterial 16S rRNA from fracture gaps
was found positive in 59 out of 95 patients from group A
(56.8%) and in 75 out of 115 from group B (65.4%, NS).
Negative bacterial cultures with positive 16S rRNA
ampliﬁcations were observed in 31.5% cases from group A
and 50% in group B.
Evaluation of mutations
The genotype frequencies of the whole investigated and
reference ethnic group did not differ by more than 5%
meeting the conditions for statistical comparison of clinical
groups. Also, there were no differences in the demographic
data between patients from investigated groups A and B.
Analysis of TLR4 gene polymorphism
The frequency rate of 1/W (Asp299Gly) and 2/W
(Thr399Ile) was estimated in the subgroups (a) non-healing
infected versus non-healing sterile, (b) non-healing infec-
ted versus healing infected, (c) non-healing sterile versus
healing sterile and (d) healing infected versus healing
sterile, subgroups. The occurrence of mutated 1/W but not
2/W was signiﬁcantly higher (P\0.05) in subgroup (a) in
the non-healing infected than sterile (P\0.05) (Fig. 1a).
In subgroup (b) 1/W mutated gene frequency was also
higher in the non-healing infected than healing infected;
however, the difference was not signiﬁcant (Fig. 1b). There
were no statistically signiﬁcant differences in 1/W and 2/W
frequency in group (c) of sterile non-healing and healing
fractures (Fig. 1c) and healing infected and sterile
(Fig. 1d). Taken together, mutation of TLR4 1/W gene was
found highest in the infected non-healing subgroup.
Analysis of TGF-b gene polymorphism
In the TGF-b codon 10 a signiﬁcantly higher frequency of
mutated homozygote T and heterozygote C/T in the non-
healing infected versus non-healing sterile was observed
(P\0.05) (Fig. 2a). Similar difference was observed in
the non-healing infected versus healing infected subgroup
(P\0.05) (Fig. 2b). In the subgroups without infection no
differences between wild and mutated gene frequencies
were seen (Fig. 2c), whereas in the healing subgroup
dominated the wild homozygote C (Fig. 2d).
Analysis of other genes polymorphism
The genetic analysis of mutation frequency of genes for
CRP (G1059C), IL1ra (genotype 2/2), IL-6 (G176C),
CD14 (G-159T), TLR2 (G2259A) and CCR2 (G190A) did
not reveal differences between (a) non-healing infected and
non-healing sterile, (b) non-healing infected and healing
infected, (c) non-healing sterile and healing sterile and (d)
healing infected and healing sterile subgroups.
Proteins in fracture gaps
Western blot analysis of the fracture callus key factors
playing role in the bone union process and skeletal tissue
Fig. 1 Comparison of the frequency rate of TLR4 gene mutation in
positions Asp299Gly (left) and Thr399Ile (right) marked as 1/W and
2/W, respectively, a in patients with delayed fracture healing and
viable bacteria isolated from fracture gaps (darkly shaded bar) and
patients with delayed healing and sterile fracture gaps (lightly shaded
bar). W wild allele; 1/W, 2/W mutations (%), Chi-square test,
*P\0.05, b with delayed healing and bacteria isolated from fracture
(darkly shaded bar) and patients with uneventful healing fractures
also with bacteria (lightly shaded bar) (NS), c with delayed healing
and sterile gaps (darkly shaded bar) and patients with uneventful
healing fractures also with sterile gaps (lightly shaded bar) (NS),
d with uneventful healing and bacteria isolated from fracture (darkly
shaded bar) and uneventful healing fractures also without bacteria
(lightly shaded bar) (NS)
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123regeneration showed reduced expression of all investigated
factors in the delayed healing fractures compared with
healing uneventfully. Statistically signiﬁcant changes were
observed for TGF-b, PDGF and collagen type I
[0.85 ± 0.59 vs. 1.56 ± 0.96; 0.16 ± 0.07 vs. 1.55 ± 1.00
and 0.75 ± 0.52 vs. 1.9 ± 0.49 (optical density ratio),
respectively] (all P\0.05) (Fig. 3). Insulin-like growth
factor (IGF-1) and bone morphogenetic protein 2 (BMP-2)
showed an insigniﬁcant decrease.
Discussion
Delayed fracture repair with lack of contact between bone
fragments including bone fragment loss was observed in
above 10% of our clinical material. Approximately 35% of
these cases could be attributed to unsuccessful surgery or
immobilization. The remaining 65% suffered from delayed
fracture repair without known causative factors. Since our
previous data showed that fracture gaps of non-healing
fractures are not sterile [7], we concentrated upon genetic
background factors crucial for pathogen recognition and
elimination, namely CRP (G1059C), IL1ra (genotype 2/2),
IL-6 (G176C), CCR2 (G190A), CD14 (G-159T), TLR2
(G2259A) and TLR4 (Asp299Gly and Thr399Ile) and
wound healing TGF-b (G25C). Mutation at the listed
points could predispose for bacterial colonization of
tissues.
In our studies, bacterial isolates were detected in 31% of
non-healing gaps compared with 16% in the uneventfully
healing fractures. Beside live bacterial cells, the presence
of bacterial DNA (16S rRNA) was documented in around
60% in both groups. This material originated from both
live and dead bacteria. Since frequency of microbial
genetic material validated by 16S rRNA was similar in
both A and B groups, but frequency of live bacteria dif-
fered signiﬁcantly, we concluded that there was impair-
ment of the mechanisms controlling live bacterial cell
recognition and elimination. The question, whether patho-
gens regularly reside in deep tissues or colonize them after
trauma, as well as how they can affect and are affected by
host immune cells enabling them to survive without
induction of inﬂammation, remains unanswered.
In all subgroups with viable pathogens isolated from
fracture gaps the frequency of TLR4 mutated allel 1/W was
higher, compared with subgroups with sterile fracture gaps.
Each TLR enables recognition of a speciﬁc molecule.
Fig. 2 Comparison of the frequency rate of TGF-b codon 10 gene
mutation a in patients with delayed fracture healing and viable
bacteria isolated from fracture gaps (darkly shaded bar) and patients
with delayed healing and sterile fracture gaps (lightly shaded
bar).W wild allele; 1/W, 2/W mutations (%), Chi-square test,
*P\0.05, b with delayed healing and bacteria isolated from fracture
(darkly shaded bar) and patients with uneventful healing fractures
also with bacteria (lightly shaded bar) (NS), c with delayed healing
and sterile gaps (darkly shaded bar) and patients with uneventful
healing fractures also with sterile gaps (lightly shaded bar) (NS),
d with uneventful healing and bacteria isolated from fracture (darkly
shaded bar) and uneventful healing fractures also without bacteria
(lightly shaded bar) (NS)
IGF-1 BMP-2 COL1A PDGF TGF-beta
0,00
0,50
1,00
1,50
2,00
2,50
3,00
Group A  Group B
Fig. 3 Western blot results of expression of IGF-1, BMP-2, Coll-1A,
PDGF and TGF-b in fracture gap tissue of non-healing (group A)
versus healing (group B) fractures (optical density units, n = 26,
mean values ± SD). *P\0.05, Chi-square test
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123TLR4s are activated by LPS, HSP-60 and HSP-70. Also,
staphylococcal exotoxin and leukocidin possess the capa-
bility to activate TLR4 [8]. These are mainly the live
proliferating bacterial cells which are easily recognized by
the host macrophage TLR4s [9]. Single nucleotide muta-
tions of genes coding TLRs and their receptors are able to
hinder the process of pathogen recognition and elimination.
TLR4 mutations were reported to correspond with pro-
longed pathogen elimination [10] and increased number of
infectious diseases, such as oral infections (periodontitis),
recurrent lung infections and others [11, 12]. Montes et al.
[13] showed an increased risk of musculoskeletal infections
in Asp299Gly mutants of gene coding TLR4. In other
studies single-nucleotide polymorphism of genes encoding
CD14 (C-159T) and TLR4 (Asp299Gly) was reported to
increase susceptibility of bacterial [14] and fungal infec-
tions [15].
The fracture gaps also contained bacterial genetic
material (16S rRNA). Bacterial DNA of disintegrated
microbes can be stored in tissue matrix or be present in
local macrophages in a ‘‘dormant’’ state, not activating the
host immune cells because of lack of direct physical con-
tact with TLR4. However, activation may take place during
tissue mechanical destruction and abundant recruitment of
host immune cells. Subsequently bacterial genetic material
will be eliminated. Mutation of TLR4 genes can make
them ineffective in recognition of 16S RNA. Our cases
with no TLR4 mutation and satisfactory bone union despite
the fact that the presence of viable pathogens in the fracture
gap proves abnormal function of the mutated TLR4 1/W
gene.
TGF-b plays a key role in healing and regeneration of
soft tissue wounds and bone fractures. Atilla et al. [16] and
Babel et al. [17] reported C-allele bearer of the TGF-b gene
for increased risk of periodontitis. TGF-b codon 25 gene
polymorphisms (GG allele) were also reported to predis-
pose to bacterial and viral infections [18]. Although the
correlation of TGF-b codon 25 polymorphism with
impaired healing was documented, such a correlation could
not be found for codon 10 [19]. In our studies, the TGF-b
codon 10 showed signiﬁcantly higher frequency of mutated
homozygote T and heterozygote C/T in the non-healing
infected versus non-healing sterile (P\0.05). Similar
difference was observed in the non-healing infected versus
healing infected subgroups. In the subgroups without
infection no differences between wild and mutated gene
frequencies were observed. Observed by us TGF-b genetic
proﬁle correlated with the expression of TGF-b proteins in
gap tissue validated by western blot analysis. There was
signiﬁcantly less TGF-b protein in the non-healing infected
compared with healing non-infected gap tissue. The same
was observed for all the remaining proteins as IGF 1, BMP,
Coll 1A and PDGF. This low protein expression might be
the effect of enzymatic activity of bacterial cells as well as
genetic defects.
We did not observe signiﬁcant differences in fre-
quency of mutated genes for CRP (G1059C), IL1ra
(genotype 2/2), IL-6 (G176C), CD14 (G-159T), TLR2
(G2259A) and CCR2 (G190A) between the non-healing
and healing fractures, although its has been reported that
these mutant genes may play role in wound healing and
inﬂammation.
IL-1ra polymorphism was reported to predispose to
loosening of the orthopedic implants [20], most probably
due to the impact on expression of molecular markers of
systemic inﬂammation.
Kolundzic ´ et al. [21] showed that IL-6 polymorphism G-
174A increases the risk of implant loosing, but Malik et al.
[22] found no correlation with IL-6 G-174C polymorphism
and an increased risk of septic loosening of the hip
endoprosthesis.
Two polymorphisms in the exon part of TLR2, which
attenuate receptor signaling, enhance the risk of acute
severe infections. Lorenz et al. [23] reported on the clinical
importance of mutations in TLR2 and susceptibility to
staphylococcal infection.
CCR2, chemokine MCP-1/CCL2 ligand, regulates
inﬁltration of mononuclear cells to the sites of inﬂamma-
tion, playing the role in control and elimination of bacterial
infections [24].
Taken together, we showed that individuals bearing T
and C/T allele of TGF-b gene codon 10, and mutated TLR
4 gene W/1 (Asp299Gly) may be predisposed to impaired
recognition and elimination of bacteria, leading to pro-
longed pathogen existence in fracture gaps and pathogen,
depending on fracture healing delays. In our studies, CRP
(G1059C), IL1ra (genotype 2/2), IL-6 (G176C), CD14 (G-
159T), TLR2 (G2259A) and TLR4 (Thr399Ile) polymor-
phisms did not coincide with delay of bone fracture
healing.
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